ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,201Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 130

$680K Total Retail Price of All Prescriptions

Rank: 3 out of 130

790 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,506 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
PRAVASTATIN SODIUM 802 733 1 18
METOPROLOL TARTRATE 583 559 2 1
METOPROLOL SUCCINATE 535 468 3 3
ATORVASTATIN CALCIUM 534 507 4 9
CLOPIDOGREL 526 456 5 11
ISOSORBIDE MONONITRATE ER 511 488 6 10
WARFARIN SODIUM 434 425 7 8
AMLODIPINE BESYLATE 428 410 8 7
LOSARTAN POTASSIUM 413 394 9 14
PLAVIX 366 338 10 13
PROPAFENONE HCL 329 329 11 38
FUROSEMIDE 325 309 12 5
LISINOPRIL 321 282 13 4
CARVEDILOL 291 247 14 6
LEVOTHYROXINE SODIUM 264 256 15 39
SIMVASTATIN 243 233 16 2
POTASSIUM CHLORIDE 222 218 17 16
AMIODARONE HCL 208 195 18 22
CRESTOR 199 192 19 19
FENOFIBRATE 187 182 20 33
ZETIA 181 175 21 26
HYDROCHLOROTHIAZIDE 171 157 22 20
ATENOLOL 160 154 23 12
VERAPAMIL ER 149 143 24 51
DIGOXIN 135 127 25 15
CLONIDINE HCL 134 134 26 43
BENAZEPRIL HCL 131 123 27 32
TRICOR 125 117 28 67
PACERONE 124 118 10 29 44
AMLODIPINE BESYLATE-BENAZEPRIL 97 94 30 61
ENALAPRIL MALEATE 94 90 31 27
LANSOPRAZOLE 93 83 32 88
NITROSTAT 90 82 33 23
SOTALOL 83 80 34 21
DILTIAZEM 24HR CD 79 79 35 24
LIPITOR 76 76 36 52
DIOVAN 76 73 36 30
DISOPYRAMIDE PHOSPHATE 74 72 R 10 38 95
IRBESARTAN 69 67 39 97
TRIAMTERENE-HCTZ 69 69 39 46
TRILIPIX 66 57 41 98
ALLOPURINOL 63 63 42 62
METFORMIN HCL 62 62 43 73
PANTOPRAZOLE SODIUM 61 61 44 68
BENICAR 61 49 44 83
RAMIPRIL 60 60 46 28
FLECAINIDE ACETATE 58 58 47 41
KLOR-CON M20 58 58 47 58
BYSTOLIC 58 58 47 36
OMEPRAZOLE 57 46 50 34
SPIRONOLACTONE 52 52 51 17
NEXIUM 50 50 52 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.